Topline: A large real-world cohort study suggests that selective serotonin reuptake inhibitors (SSRIs) may contribute to faster cognitive decline in individuals with dementia. However, researchers caution against premature changes in treatment guidelines, as the clinical significance of the findings remains uncertain.
Study Details: Dementia is often acc…
